Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods
Monitoring of direct inhibitors of thrombin (DTI) is critical for their safe and effective use as anticoagulants. We examined samples containing several concentrations of argatroban or lepirudin in reconstituted standard human plasma and plasma from medical outpatients and intensive care patients. P...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Clinical and applied thrombosis, hemostasis
Year: 2011, Jahrgang: 17, Heft: 5, Pages: 549-555 |
| ISSN: | 1938-2723 |
| DOI: | 10.1177/1076029610382651 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1177/1076029610382651
|
| Verfasserangaben: | Boris Ivandic, and Markus Zorn |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1808826949 | ||
| 003 | DE-627 | ||
| 005 | 20220820212857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220704s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/1076029610382651 |2 doi | |
| 035 | |a (DE-627)1808826949 | ||
| 035 | |a (DE-599)KXP1808826949 | ||
| 035 | |a (OCoLC)1341463325 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ivandic, Boris |e VerfasserIn |0 (DE-588)1031172165 |0 (DE-627)735782245 |0 (DE-576)378581821 |4 aut | |
| 245 | 1 | 0 | |a Monitoring of the anticoagulants argatroban and lepirudin |b a comparison of laboratory methods |c Boris Ivandic, and Markus Zorn |
| 264 | 1 | |c 2011 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published September 11, 2010 | ||
| 500 | |a Gesehen am 04.07.2022 | ||
| 520 | |a Monitoring of direct inhibitors of thrombin (DTI) is critical for their safe and effective use as anticoagulants. We examined samples containing several concentrations of argatroban or lepirudin in reconstituted standard human plasma and plasma from medical outpatients and intensive care patients. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT) were determined using automated analyzers. Ecarin clotting time (ECT) was measured using a 10 IU/mL dilution of ecarin in 0.05 mol/L CaCl2. Calibration curves were approximately linear for TT and ECT in samples containing argatroban and lepirudin, respectively. Activated partial thromboplastin curves reached a plateau at DTI concentrations ≥2 µg/mL, suggesting that the aPTT may not reliably detect overdosing. Prothrombin time increased exponentially. A broad range of clotting times was seen in patient samples with all tests suggesting that individual morbidity and therapies may strongly influence test results and may lead to underestimation of DTI doses. | ||
| 650 | 4 | |a anticoagulants | |
| 650 | 4 | |a in vitro diagnostic systems | |
| 650 | 4 | |a thrombosis prophylaxis | |
| 700 | 1 | |a Zorn, Markus |d 1964- |e VerfasserIn |0 (DE-588)1033873721 |0 (DE-627)745111483 |0 (DE-576)381543137 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and applied thrombosis, hemostasis |d Thousand Oaks, Calif. : Sage, 1995 |g 17(2011), 5, Seite 549-555 |h Online-Ressource |w (DE-627)510464181 |w (DE-600)2230591-9 |w (DE-576)276272900 |x 1938-2723 |7 nnas |a Monitoring of the anticoagulants argatroban and lepirudin a comparison of laboratory methods |
| 773 | 1 | 8 | |g volume:17 |g year:2011 |g number:5 |g pages:549-555 |g extent:7 |a Monitoring of the anticoagulants argatroban and lepirudin a comparison of laboratory methods |
| 856 | 4 | 0 | |u https://doi.org/10.1177/1076029610382651 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220704 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1033873721 |a Zorn, Markus |m 1033873721:Zorn, Markus |d 910000 |d 910100 |e 910000PZ1033873721 |e 910100PZ1033873721 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 1031172165 |a Ivandic, Boris |m 1031172165:Ivandic, Boris |d 50000 |e 50000PI1031172165 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1808826949 |e 4160714153 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"pubHistory":["1.1995 -"],"part":{"text":"17(2011), 5, Seite 549-555","volume":"17","extent":"7","year":"2011","pages":"549-555","issue":"5"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 25.05.2020","Fortsetzung der Druck-Ausgabe"],"disp":"Monitoring of the anticoagulants argatroban and lepirudin a comparison of laboratory methodsClinical and applied thrombosis, hemostasis","language":["eng"],"recId":"510464181","title":[{"title":"Clinical and applied thrombosis, hemostasis","title_sort":"Clinical and applied thrombosis, hemostasis"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Thousand Oaks, Calif.","publisher":"Sage","dateIssuedKey":"1995","dateIssuedDisp":"1995-"}],"id":{"eki":["510464181"],"zdb":["2230591-9"],"issn":["1938-2723"]}}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Boris Ivandic, and Markus Zorn"]},"id":{"doi":["10.1177/1076029610382651"],"eki":["1808826949"]},"origin":[{"dateIssuedDisp":"2011","dateIssuedKey":"2011"}],"language":["eng"],"recId":"1808826949","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["First published September 11, 2010","Gesehen am 04.07.2022"],"person":[{"given":"Boris","family":"Ivandic","role":"aut","display":"Ivandic, Boris","roleDisplay":"VerfasserIn"},{"given":"Markus","family":"Zorn","role":"aut","roleDisplay":"VerfasserIn","display":"Zorn, Markus"}],"title":[{"title":"Monitoring of the anticoagulants argatroban and lepirudin","subtitle":"a comparison of laboratory methods","title_sort":"Monitoring of the anticoagulants argatroban and lepirudin"}]} | ||
| SRT | |a IVANDICBORMONITORING2011 | ||